Agenda-setting capability emerges when research institutions collectively shape policy discussions, investment priorities, ...
India Today on MSN
This new 'pacemaker' could be a game-changer in managing diabetes
Biorad Medisys is developing an implantable device that uses vagus nerve stimulation to regulate blood sugar and appetite, ...
On 18 November, the Chief Executive’s Policy Unit (CEPU) of the Government of the Hong Kong Special Administrative Region, the National Academy of Economic Strategy of the Chinese Academy of Social ...
Q2 The plan calls for advancing high-level scientific and technological self-reliance and fostering new quality productive ...
Australian biotechnology giant CSL has announced plans for a $2.3 billion expansion of its manufacturing operations in the ...
Gaslight Square is a five-building complex on 2.7 acres in the Carroll-Camden Industrial Area. It was originally constructed ...
Clinical Trials Arena on MSN
Redefining clinical trials in oncology and rare diseases across the Europe
At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical ...
Korean biotechnology company, Nature Cell, is planning to open a stem cell facility in Baltimore, bringing 500 new jobs, the ...
Six months after launching research-grade human collagen, Phoenix-based Humabiologics announced its first expansion, to ...
Making biotech more diverse and fair is a big deal, fixing past mistakes and making sure everyone has a chance to be involved ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
On its face, Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio) | On its face, there wasn’t much notable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results